Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Ret Proto-Oncogene antibody (pTyr981) (Biotin)

This anti-Ret Proto-Oncogene antibody is a Rabbit Polyclonal antibody detecting Ret Proto-Oncogene in . Suitable for Human, Mouse and Rat.
Catalog No. ABIN6875945

Quick Overview for Ret Proto-Oncogene antibody (pTyr981) (Biotin) (ABIN6875945)

Target

See all Ret Proto-Oncogene (RET) Antibodies
Ret Proto-Oncogene (RET)

Reactivity

  • 173
  • 96
  • 72
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Mouse, Rat

Host

  • 178
  • 44
  • 2
  • 2
  • 1
  • 1
Rabbit

Clonality

  • 176
  • 52
Polyclonal

Conjugate

  • 96
  • 14
  • 11
  • 9
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
This Ret Proto-Oncogene antibody is conjugated to Biotin

Application

Please inquire
  • Binding Specificity

    • 24
    • 20
    • 18
    • 15
    • 15
    • 15
    • 11
    • 9
    • 9
    • 8
    • 8
    • 8
    • 6
    • 6
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pTyr981

    Cross-Reactivity

    Human, Mouse (Murine), Rat (Rattus)

    Characteristics

    c-Ret (Phospho-Tyr981) Conjugated Antibody
  • Application Notes

    Biotin conjugated: Working with enzyme-conjugated streptavidin. ELISA: 1: 200 - 1: 1,000; Western Blot: 1: 200 - 1: 1,000; IHC/ICC: 1: 100 - 1: 500; Flow Cytometry: 1: 50 - 1: 250; IF: 1: 100 - 1: 500.

    Restrictions

    For Research Use only
  • Storage

    4 °C

    Storage Comment

    Store at 4°C for 6 months.
  • Target

    Ret Proto-Oncogene (RET)

    Alternative Name

    c-Ret

    Pathways

    RTK Signaling, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
You are here:
Chat with us!